Pfizer is seeking new vaccine opportunities across the age spectrum as it broadens its portfolio by delivering shots into the arms of adolescents and the elderly, as well as infants. Previously reliant on just one vaccine, the blockbuster Prevnar, the U.S. drugmaker is now expanding its product line-up through both in-house development and by shopping for assets in a consolidating sector.
Hey, check out all the research scientist jobs. Post your resume today!
Hey, check out all the research scientist jobs. Post your resume today!